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In human and ovine fetuses, glucocorticoids stimulate leptin secretion, although the extent to
which leptin mediates the maturational effects of glucocorticoids on pulmonary development is
unclear. This study investigated theeffects of leptin administrationon indicesof lung structureand
function before birth. Chronically catheterized singleton sheep fetuses were infused iv for 5 days
with either saline or recombinant ovine leptin (0.5 mg/kg  d leptin (LEP), 0.5 LEP or 1.0 mg/kg  d,
1.0 LEP) from 125 days of gestation (term 145 d). Over the infusion, leptin administration in-
creasedplasma leptin, butnot cortisol, concentrations.On the fifthdayof infusion, 0.5 LEP reduced
alveolar wall thickness and increased the volume at closing pressure of the pressure-volume de-
flation curve, interalveolar septal elastin content, secondary septal crest density, and the mRNA
abundance of the leptin receptor (Ob-R) and surfactant protein (SP) B. Neither treatment influ-
enced static lung compliance, maximal lung volume at 40 cmH2O, lung compartment volumes,
alveolar surface area, pulmonary glycogen, protein content of the long form signaling Ob-Rb or
phosphorylated signal transducers and activators of transcription-3, or mRNA levels of SP-A, C, or
D, elastin, vascular endothelial growth factor-A, the vascular endothelial growth factor receptor
2, angiotensin-converting enzyme, peroxisome proliferator-activated receptor , or parathyroid
hormone-related peptide. Leptin administration in the ovine fetus during late gestation promotes
aspects of lung maturation, including up-regulation of SP-B. (Endocrinology 157: 395–404, 2016)
Maturation of the fetal lungs close to term is essentialfor normal respiratory function at birth and the suc-
cessful transition from a placental to a pulmonary supply
of oxygen. A number of structural and functional changes
occur in the fetal lungs, including development of the diffu-
sion exchange surface by thinning of alveolar septa, vascular
remodeling and removal of lung liquid; expression of elastin
and activation of surfactant synthesis and secretion in type II
pneumocytes to improve lung compliance; and up-regula-
tion of angiotensin-converting enzyme (ACE) activity to in-
duce bioavailability of angiotensin II (1–4). Pretermdelivery
before these changes take place often leads to respiratory
distress syndrome (RDS) in the neonate. In England and
Wales,prematurityaffectsabout7%ofallbirthsandaround
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24 babies die each week as a result of respiratory and other
complications arising from preterm birth (5).
Glucocorticoids are well known to promote matura-
tion of the fetal lungs (3). Close to term, a rise in cortisol
in the fetal circulation stimulates structural and functional
maturation of the lungs in preparation for birth. In addi-
tion, antenatal synthetic glucocorticoid treatment, such as
dexamethasone, administered to pregnant women at risk
of preterm delivery, has markedly reduced neonatal mor-
tality and the incidence ofRDS in premature infants (6, 7).
The maturational actions of endogenous and exogenous
glucocorticoids on pulmonary structure and function in
utero may be direct and/or indirect. Glucocorticoid re-
sponse elementshavebeen identified in several of the genes
essential for the production of surfactant (3). In addition,
the effects of glucocorticoids on pulmonary maturation
may bemediated by other endocrine and/or paracrine sys-
tems. For example, the rise in pulmonary ACE concentra-
tion induced by glucocorticoids in fetal sheep near term
depends on an intact thyroid gland and up-regulation of
thyroid hormone activity (8).
Previous studies have suggested that leptin may act as
a hormonal signal to mediate, at least in part, the matu-
rational effects of glucocorticoids in utero. In fetal sheep,
adipose leptin mRNA abundance and plasma leptin con-
centration increase towards term in association with the
prepartum cortisol surge (9, 10). Developmental incre-
ments in leptin synthesis and secretion are abolished by
removal of the fetal adrenal gland and prevention of the
prepartum cortisol surge, and can be induced prematurely
by endogenous and exogenous glucocorticoid treatment
(9, 10). Clinical studies have also shown a significant pos-
itive relationship between umbilical concentrations (in the
fetal circulation) of leptin and cortisol in newborn full-
term human infants, independent of gender, birth weight
and gestational age (11), and that umbilical leptin con-
centrations are increased 3-fold in preterm infants deliv-
ered after their mothers were treated with antenatal glu-
cocorticoids (12).
Leptin receptors (Ob-R), including the long-form sig-
naling isoform Ob-Rb, are expressed in the fetal lungs of
a variety of mammalian species (13–16), and studies in
vitro using fetal tissue suggest that leptin may be an im-
portant regulator of pulmonarydevelopment before birth.
Leptin treatment increases surfactant protein (SP) mRNA
andprotein levels in lung explants from fetal rats (17), and
promotes surfactant phospholipid synthesis in type II
pneumocytes isolated from fetal rats and rabbits (18, 19).
However, the role of leptin in the control of lung devel-
opment in vivo is unclear, particularly in species like the
sheep and human where alveolar formation begins before
birth. Therefore, this study examined the effects of an iv
infusion of recombinant ovine leptin on structural and
molecular indicesofpulmonarydevelopment in the chron-
ically catheterized fetal sheep. It was hypothesized that
leptin exposure in utero would increase static lung com-
pliance, promote thinning and expansion of the alveolar
diffusion surface and up-regulate gene transcript levels of
elastin, SPs, andACE. The study also examined the effects
of leptin on local factors known to influence lung devel-
opment, and specifically type II pneumocyte function,
such as vascular endothelial growth factor (VEGF)-A and
its receptor (VEGFR2), peroxisomeproliferator-activated
receptor (PPAR), and parathyroid hormone-related pep-
tide (PTHrP) (20–22).
Materials and Methods
Animals
Thirty pregnantWelshMountain ewes of known gestational
age and carrying singleton fetuseswere housed in individual pens
and fed concentrates (200 g/d; 18%protein and10MJ/kg; Sheep
Nuts 6; H&G Beart) with hay, water, and a mineral block ad
libitum. The animals consumed between 8–11 MJ/d of metab-
olizable energy and were weighed on the day of surgery. All
surgical and experimental procedures were carried out in accor-
dance with the United Kingdom Animals (Scientific Procedures)
Act 1986 and were approved by the local animal ethics commit-
tee at the University of Cambridge, United Kingdom.
Surgical procedures
The pregnant ewes were fasted for 18–24 hours before sur-
gery but had free access to water. At between 118 and 120 days
of pregnancy (term 145 d), the ewes were anesthetized with
halothane (1.5–2.0% in O2-N2O) and positive pressure venti-
lation. Intravascular catheters were inserted into the femoral
artery and vein of the fetus and the femoral artery of the ewe
using techniques described previously (23). The catheters were
exteriorized and secured in a bag sutured to the flank of the ewe.
At surgery, all fetuseswere administeredwith 100-mg ampicillin
iv (Penbritin, Beecham Animal Health) and 2-mg gentamycin iv
(Frangen-100; Biovet). The ewes were administered with anti-
biotics im (procainepenicillin,Depocillin,Mycofarm)on theday
of surgery and for 3 days thereafter.
Experimental procedures
Fetal leptin infusion and blood sampling
Starting at 124–125 days of gestation, the fetuses were di-
vided randomly into 3 treatment groups and infused iv for 5 days
with either saline (0.9% saline, n 13, 6 male and 7 female) or
recombinant ovine leptin at 2 doses, 0.5 mg/kg  d (0.5 LEP; n
10, 5 male and 5 female) and 1.0 mg/kg  d (1.0 LEP; n  7, 3
male and 4 female; Protein Laboratories) (24). The infusions
were administered via the fetal venous catheter using a Graseby
portable infusion pump held in the catheter bag and set at a rate
of 3 mL/d. Arterial blood from the fetus and ewe (3 mL) was
collected daily from 2 days before and throughout the 5 days of
infusion.
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Arterial blood gas status was assessed in the fetal and mater-
nal blood samples using an ABL330 Radiometer analyzer (Ra-
diometer) corrected for fetal body temperature to measure pH,
partial pressure of oxygen and carbon dioxide, and using an
OSM2 hemoximeter (Radiometer) for hemoglobin content and
O2 saturation. Arterial blood glucose and lactate concentrations
were measured using a 2300 Statplus autoanalyser (YSI). All
blood samples collected were placed into EDTA-containing
tubes and centrifuged at 1000g and 4°C for 5 minutes. The
plasma samples were stored in aliquots at20°C until analysis.
Postmortem procedures
On the fifth day of infusion (129–130 d of gestation), the
fetuses were delivered by Caesarean section with the ewe under
general anesthesia (20-mg/kg sodium pentobarbitone iv). At de-
livery, umbilical arterial blood (10 mL) was collected from the
fetus before the administration of a lethal dose of barbiturate to
both the ewe and fetus (200-mg/kg sodium pentbarbitone iv).
The fetus was weighed and a lung function test was performed
immediately. In all fetuses, bodyweight and crown-rump-length
(CRL) were measured and used to calculate body mass index
(BMI) (kg/m2) and ponderal index (PI) (kg/m3). The placental
cotyledons were dissected, weighed, and categorized into pla-
centome types A, B, C, and D, based on the degree of eversion of
the hemophagous zone: the hemophagous zone (the area of ex-
travasated maternal blood at the maternal-fetal interface) is in-
verted into the type A placentomes and everted over the tissue of
the type D placentome with intermediate morphology in types B
and C (25). The relative proportions of the placentome types are
known to be influenced by circulating glucocorticoids in the
sheep fetus (25). Classification of placentome type was carried
out by a single investigator (F.B.P.W.). The remaining placental
membranes and uterus were also weighed.
Lung function test
Immediately after the fetus was delivered, lung liquid was
drained by gravity, a tracheotomywas performed to intubate the
trachea, and the lungs were exposed via a ventral thoracotomy.
Static lung compliancewasmeasuredwith the fetus in the supine
position using a water manometer. The lungs were inflated to a
maximal luminal pressure of 40 cmH2O and then progressively
deflated in 5 cmH2O steps while recording the volume on a
syringe, until return to zero pressure. Maximum volume at 40
cmH2O (V40) and volume at 0 cmH2O (volume at closing pres-
sure) were measured from the pressure-volume curves for each
fetus. Static lung compliance was calculated as the slope of the
deflation limb of the pressure-volume curve between 10 and 30
cmH2O. After static compliance was measured, the fetal lungs
were weighed and dissected. The right upper lobe was isolated
and inflation-fixed with 4% paraformaldehyde (with 0.2% glu-
teraldehyde in 0.1M phosphate buffer; pH 7.4) at a pressure of
20 cmH2O for at least 30 minutes. The inflated lobe was ligated
to maintain the perfusion-fixed pressure, and the volume was
determined by water displacement. The lobe was then placed in
a container of fresh fixative for 2 weeks. The left upper lobe of
the fetal lungwasweighed, freeze dried overnight and reweighed
to determine pulmonary water content. Samples from the lower
right lobewere frozen in liquid nitrogen and stored at80°C for
subsequent molecular analyses and Western blotting.
Stereological analyses
After 2weeks in fixative, a 1.01.00.5-cmcuboidwas cut
from the inflated lung lobe; the volumewas determined bywater
displacement, and the tissue was embedded in paraffin wax for
morphometric analysis. Sections were serially cut (5 m)
throughout the whole tissue and 10 sections every 100 sections
were collected and mounted on polysine glass slides. The lung
sections were stained with hematoxylin and eosin for the deter-
mination of alveolar structure, or Miller’s elastin stain for the
measurement of elastin content.
Stereological analysis of lung sampleswas performed blind to
the treatment group using a light microscope (Olympus U-Spt)
equippedwitha computer-assisted stereology system (CAST2.0;
Olympus). Using point counting with a grid containing 8  8
points and 20 fields of view per section in 10 sections at 40
magnificationwith aminimumof 200 counts, the percentages of
section occupied by alveolar airspace (alveolar lumen), alveolar
tissue (alveolar walls), extra-alveolar airspace (bronchial and
bronchiolar airspaces), and extra-alveolar (bronchial, bronchio-
lar, vascular, and connective tissue). Alveolar wall thickness was
measuredusingorthogonal intercepts, adjusted for tissue shrink-
age, andwas expressed as the harmonic mean value in 2 sections
per animal using 6 lines per field of view and 20 fields of view per
section at40magnification. Alveolar surface area per unit vol-
ume (Sv), also adjusted for tissue shrinkage, was measured using
stereological cycloids (8 8 cycloids in 10 fields of view at40
magnification) and was calculated using the next equation: Sv
2(I)/(l/p(P)), whereI is the sum of the intersections,P is the
sum of points on lung tissue, and l/p is the length of the cycloid
per point (26m) (26). In addition, the volume fractionof elastin
in interalveolar septae and secondary septal crests, and the den-
sity of secondary septal crests corrected for tissue shrinkage,
were measured in 5 sections by point counting using a 10  10
grid and 20 fields of view per section at 40 magnification.
Biochemical and molecular analyses
Plasma hormone concentrations and pulmonary gly-
cogen content
Plasma leptin concentration was measured by RIA using
ovine leptin standards as described previously (10, 27); the lower
limit of detection was 0.09 ng/mL and the interassay coefficient
of variation was 5%. Total plasma cortisol concentration was
measured by ELISA (IBL International); the sensitivity of the
assay was 2.5 ng/mL and the interassay coefficient of variation
was less than 8%. Pulmonary glycogen content was determined
using an enzymaticmethod as described previously (28) andwas
expressed as milligrams of glucose per gram of lung tissue.
Quantitative RT-PCR
Tissue RNA was isolated from 15-mg samples of fetal lung
(saline n  6; 0.5 LEP n  10; 1.0 LEP n  7), and reverse
transcription was carried out as described previously (29). Taq-
Man quantitative real-time-PCR was performed to measure
mRNA abundance of target genes. Samples were analyzed using
a TaqMan 7900HT, and data were acquired and processed with
Sequence Detector v.2.3 software (Applied Biosystems) (29).
The ovine mRNA probes and primers for leptin, the active long
form of the leptin receptor (Ob-Rb), and all forms of the leptin
receptor (Ob-R), elastin, VEGF-A and VEGFR2, ACE, PPAR,
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bovine PTHrP, and SP-A, SP-B, and SP-C, and bovine SP-D are
shown in Table 1. Each sample was measured in triplicate and
normalized to the geometric mean of two housekeeping genes,
glyceraldehyde-3-phosphate dehydrogenase and cyclophilin A
(Table 1). ThemRNA levels of these housekeeping genes were not
affectedby leptin treatment.For eachplate, anegative controlwith-
out cDNAwasused to ensure that no amplicon contaminationhad
occurred in the reaction, and a single cDNA sample was measured
on each plate across all assays as a quality control. In order to
compare mRNA abundance of target genes, cycle thresholds (Ct)
determined by qRT-PCR were analyzed using the Ct method as
all standard curves were linear and parallel.
Western blotting
The pulmonary protein contents of Ob-Rb and the total and
phosphorylated formsofoneof its signalingmolecules, the signal
transducers and activators of transcription-3 (STAT3), were de-
termined byWestern blotting. Frozen samples of fetal lung (100
mg) were homogenized, and the protein concentration of the
lysates were measured as described previously (29). Equal
amounts of sample protein were separated using 7.5% Mini-
PROTEANprecast gels followed by incubation overnight at 4°C
with rabbit polyclonal primary antibodies (Table 2) to 1) the
ovine long-form leptin receptor (Ob-Rb) (2-g/mL orb6312; Bi-
orbyt); 2) the mouse phosphorylated STAT3 containing Ser727
(0.5-g/mL sc-8001-R; Insight Biotechnology Ltd); or 3) the hu-
man STAT3 (1:500, 07-2173; Millipore) (29). Protein expres-
sion was visualized using ECL Plus chemiluminescence system
according to themanufacturer’s instructions (AmershamBiosci-
ences) and quantified using ImageJ software (National Institutes
ofHealth; http://rsb.info.nih.gov/ij/) after normalization to Pon-
ceau S staining (30).
Statistical analysis
Data are presented as mean  SEM. All data were analyzed
fornormality, andparametric andnonparametric testswereused
as appropriate (SPSS). The effect of the sex of the fetus on all data
was initially assessed using a two-way ANOVA with sex and
treatment as factors; no significant sex differenceswere observed
and therefore, values from male and female fetuses were ana-
lyzed together in each treatment group. Data obtained from the
3 groups were compared by one-way ANOVA followed by
Tukey’s post hoc test or Kruskal-Wallis ANOVA on Ranks fol-
lowed by Dunn’s test. Gene expression data were expressed as
fold changes in 2(Ct) values relative to the mean value of the
saline group. Repeated measures ANOVA (9 levels) was used to
analyze the deflation limb of the lung curves for each treatment
comparedwith the saline group. Repeatedmeasures ANOVA (3
levels) was used to analyze the plasma concentrations of leptin
and cortisol for each treatment compared with the saline group.
Within the saline-treated group, relationships between plasma
leptin concentration on day 5 of infusion and indices of pulmo-
nary structure and function were assessed by linear regression.
Differences where P  .05 were regarded as significant.
Results
Plasma hormone concentrations and blood gas
analyses
There was no difference in basal plasma leptin concen-
tration between the treatment groups before the infusion
period (Figure1).On the first dayafter the commencement
Table 1. Primer and Reporter Sequences Used for TaqMan qRT-PCR in the Sheep
Gene Forward Primer Sequence Reverse Primer Sequence Reporter Sequence
Reporter
Dye
Leptin CAAGACGATTGTCACCAGGATCAA CCAGTGACCCTCTGTTTGGA TCACACACGCAGTCCGT FAM
Ob-Rb (long form) GGAGACAGCCCTCTGTTAAATATGC TGAGCTGTTTATAAGCCCTTGCT CCTCCTCGGCTTCACC FAM
Ob-R (all isoforms) GAGCGCCCTTCTTACCTTTACTA CCAACCGCTGTCAGAATTTTAGGT CACAAGATGTCATATATTTTC FAM
SP-A GAGCCTGGCGAGAGAGG CTTGATGTCTGATCTCATGGAGTGT TCCTCCAGGGTTTCCAG FAM
SP-B AGCCTGGGCCTCAGACA CGGCAGAGCCAGCAGAA CAGCAGCGGTTCCCCA FAM
SP-C GCAGCAAAGAGGTCTTGATGGA GATGAGAAGGCGTTTGATGTTCAC CCGCCGGACTACTC FAM
SP-D (bovine) TaqMan(R) gene expression assays (assay ID, Bt03217554_mH; part number, 4 331 182) FAM
Elastin GCTGCAGCTGCTAAAGCA GGCTCCTAGGACACCTCCAA CCAGCGGCACCAAAT FAM
VEGF-A GCTCTCTTGGGTGCATTGGA GCCTGGGACCACTTGGC CCTTGCCTTGCTGCTCTACCTTCACCA FAM
VEGF-R2 GAACTAGAATGAGAGCCCCTGATT CCCCATGCCAGCAGTCAA ATGGTCTGGTACATTTC FAM
ACE CCTTCCCGCTACAACTATGACT GGACAACCGGAGGACAGATC ATACTTGGTTCGAAGATACC FAM
PPAR CGATTCCAGAAGTGCCTTGCT GAGATCTCTGCTAACAGCTTTTCCT CCAAACCTGATGGCATTAT FAM
PTHrP (bovine) TaqMan(R) gene expression assays (assay ID, Bt03224326_m1; part number, 4 351 372) FAM
GAPDH GCTACACTGAGGACCAGGTT AGCATCGAAGGTAGAAGAGTGAGT CTCCTGCGACTTCAAC FAM
Cyclophilin A GGTTCCTGCTTTCACAGAATAATTCC GTACCATTATGGCGTGTGAAGTCA CACCCTGGCACATAAA FAM
Abbreviation: GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
Table 2. Antibody Table
Peptide/Protein Target Antigen Sequence (if Known) Name of Antibody
Manufacturer, Catalog Number,
and/or Name of Individual
Providing the Antibody
Species Raised
in; Monoclonal
or Polyclonal
Dilution
Used
Ovine long-form leptin receptor KLH-conjugated synthetic peptide derived from
sheep leptin receptor C terminus
Antileptin receptor Biorbyt, orb6312 Rabbit; polyclonal 2 g/mL
Mouse phosphorylated STAT3
containing Ser727
Antiphosphorylated
STAT3 (Ser727)
Santa Cruz Biotechnology, Inc, sc-8001-R Rabbit; polyclonal 0.5 g/mL
Human STAT3 Anti-STAT3 Millipore, 07-2173 Rabbit; polyclonal 1:500
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of the infusion, circulating leptin concentrations increased
significantly in the fetuses treated with 0.5 LEP and 1.0
LEP, above respective basal concentrations and to con-
centrations higher than those seen in the saline group (P
.05 in all cases) (Figure 1). In the 0.5 LEP and 1.0 LEP
groups, plasma leptin remained elevated throughout the
5-day period of infusion (P  .05 on all days) (Figure 1).
Therewas a significant interaction between treatment and
time on plasma leptin concentration (P  .001), and
plasma leptin in the1.0LEPgroupwas significantlyhigher
than in the 0.5 LEP group throughout the infusion period
(P .05 on all days) (Figure 1). Plasma leptin concentra-
tion remainedunchanged in the saline-infused fetuses over
all days of study (Figure 1).
Over the period of infusion, no significant differences in
plasma cortisolwere observed eitherwithin or between each
treatment group, and no significant interactions between
treatment and time were observed (Table 3). Arterial blood
pH, partial pressure of oxygen, partial pressure of carbon
dioxide, O2 saturation, hemoglobin content, and glucose
and lactate concentrations, in the ewe and fetus were not
affected by leptin infusion and did not differ between treat-
ment groups on any day of the study (data not shown).
Body composition
No significant differences in the measures of fetal body
composition (body weight, CRL, BMI, and PI) were ob-
served after 5 days of 0.5 LEP or 1.0 LEP infusion com-
pared with the saline group (Table 3). In addition, mater-
nal body weight, absolute and relative fetal lung weights,
and pulmonary glycogen and percentage water content,
did not differ between the treatment groups (Table 3).
Leptin infusion had no effect on the total weight of pla-
Figure 1. Mean  SEM plasma leptin and cortisol concentrations in
sheep fetuses infused iv with either saline or leptin (0.5 or 1.0 LEP) for
5 days. Basal concentrations represent the mean value from the 3 days
before the start of infusion. Day 1 is the first day after infusion starts
and day 5 is the last day of infusion before delivery and tissue
collection. On each day, values with different letters are significantly
different from each other, P  .05. *, significant difference from basal
values, P  .05.
Table 3. Mean  SEM Values for Animal Morphometry, Fetal Plasma Cortisol, and Lung Measurements in the 3
Treatment Groups
Saline
(n  13)
0.5 LEP
(n  10)
1.0 LEP
(n  7)
Maternal body weight (kg) 44.8  2.2 44.1  2.4 45.6  3.8
Total placentome weight (g) 319  22 298  18 267  35
Fetal body weight (kg) 2.76  0.16 2.74  0.12 2.32  0.19
CRL (cm) 43.0  1.0 43.5  0.7 41.4  1.1
BMI (kg/m2) 14.8  0.4 14.4  0.5 13.3  0.4
PI (kg/m3) 34.4  0.9 33.2  1.2 32.2  0.5
Plasma cortisol concentration (ng/mL)
Basal 8.4  1.2 6.6  0.8 6.1  1.4
Day 5 10.4  2.1 7.1  1.3 12.0  3.7
Absolute lung weight (g) 74.4  4.5 74.1  5.2 64.0  4.3
Relative lung weight (% of body weight) 2.71  0.10 2.71  0.16 2.80  0.13
Pulmonary water content (%) 89.1  0.2 89.1  0.4 89.3  0.4
Pulmonary glycogen content (mg/g) 2.50  0.28 (n  6) 2.15  0.16 2.54  0.37
Alveolar air-space (%) 49.7  2.8 54.8  0.7 53.0  3.5
Alveolar tissue (%) 44.4  2.8 39.6  0.8 38.7  2.4
Extra-alveolar air-space (%) 2.7  0.3 2.4  0.2 3.0  0.4
Extra-alveolar tissue (%) 3.2  0.3 3.2  0.3 5.4  1.1
Alveolar wall thickness (harmonic mean, m) 9.28  0.66a 7.15  0.25b 9.88  0.43a
Alveolar surface area (cm2/cm3) 707  139 535  143 911  388
Secondary septal crest density (number/mm2) 404  33 548  65* 527  69
Relative volume of elastin
Interalveolar septae 28.9  1.5a 35.1  1.8b 31.4  2.0a,b
Secondary septal crests 11.2  1.1 12.7  1.4 11.6  1.1
Total 40.2  1.8a 47.8  2.6b 43.0  2.4a,b
For each variable, values with different letters (a, b) are significantly different from each other, one-way ANOVA, P  .05.
* Significantly different from saline group, unpaired Student’s t test, P  .05.
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centomes (Table 3), total uteroplacental weight (uterus,
placentomes, and placental membranes) or the number,
mean weight or type of placentomes (data not shown).
Fetal lung function
Significant interactions between treatment and defla-
tion pressure were observed for lung volume when it was
expressed in absolute terms or relative to lung weight or
V40 (P .05 in all cases) (Figure 2). In the fetuses infused
with 0.5 LEP, the absolute lung volumes at closing pres-
sure (0 cmH2O) and at 5 cmH2O of the deflation limb of
the pressure-volume curve were significantly greater than
those seen in the fetuses infusedwith salineor1.0LEP (P
.05 in all cases) (Figure 2A). When corrected for lung
weight, the relative lung volumes at 0, 5, and 10 cmH2O
were significantly increased in the 0.5 LEP group com-
pared with the saline or 1.0 LEP groups (P  .05 in all
cases) (Figure 2B). The lung volume expressed relative to
V40 was significantly greater in the 0.5 LEP fetuses com-
pared with the saline or 1.0 LEP-infused fetuses at 0 and
5 cmH2O (P  .05 in both cases), with a tendency to be
increased at 10 cmH2O (P  .06) (Figure 2C). The lung
pressure-volume curve, using absolute or relative data,
was not different between the 1.0 LEP and saline groups
(Figure 2). There were no significant effects of either dose
of leptin onV40 (Figure 2A) or on the slope of the deflation
curves between 10 and 30 cmH2O (data not shown).
Stereological analysis of the fetal lung
Alveolarwall thicknesswas significantly reduced in the
fetuses infused with 0.5 LEP compared with those treated
with saline and 1.0 LEP (P  .05) (Table 3). Secondary
septal crest density was not affected by leptin administra-
tion when the data were analyzed by one-way ANOVA;
however, when compared by unpaired Student’s t test, the
density of secondary septal crests in the lungs of fetuses
treated with 0.5 LEP was significantly higher than that
seen in the saline group (P  .05) (Table 3). The surface
area density, the percentage volume fractions of alveolar
airspace, alveolar tissue, extra-alveolar airspace and ex-
tra-alveolar tissue, were not affected by leptin infusion
(Table 3). On day 5 of treatment, plasma leptin concen-
tration in the saline-infused fetuses correlated positively
with the percentage volume fraction of alveolar air-space
(r  0.74, n  12, P  .05) and inversely with the per-
centage volume fraction of alveolar tissue (r0.71, n
12, P .05). The percentage volume fraction of elastin in
the interalveolar septae, and hence the total volume frac-
tion of elastin (elastin in the interalveolar septae and sec-
ondary septal crests), were significantly increased in the
fetuses infused with 0.5 LEP compared with those infused
with saline (P .05 in both cases) (Table 3); the values in
the fetuses infusedwith1.0LEPwere intermediate to those
treated with saline or 0.5 LEP (Table 3). There were no
significant differences in volume fraction of elastin in the
secondary septal crests between the treatment groups
(Table 3).
Pulmonary gene and protein expression
Using primers that recognized all forms of the leptin
receptor, Ob-R mRNA abundance tended to increase in
response to leptin treatment (P .09, one-way ANOVA);
when analyzed subsequently by unpaired Student’s t test,
pulmonary Ob-R mRNA level in the fetuses treated with
0.5 LEP was significantly greater than that seen in the
Figure 2. Mean  SEM lung volumes with deflating airway pressure,
expressed as (A) absolute values, (B) relative to lung weight, and (C)
relative to V40 in sheep fetuses infused iv with either saline or leptin
(0.5 or 1.0 LEP) for 5 days. *, significant difference from saline and 1.0
LEP group, P  .05 (#, P  .06).
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saline group (P .05) (Figure 3A). Transcript and protein
levels of the long-form leptin receptor, Ob-Rb, and the
phosphorylated STAT3 to STAT3 protein ratio, in the
fetal lungs were not affected by 0.5 LEP or 1.0 LEP treat-
ment (Figure 3, B–D). Pulmonary mRNA abundance of
SP-Bwas significantly elevated in the fetuses of the0.5LEP
group compared with those in the saline group (P  .05)
(Figure 4); however, SP-B mRNA level in the 1.0 LEP
fetuses remained intermediate to the level measured in the
saline and 0.5 LEP fetuses (Figure 4). ThemRNA levels of
SP-A, SP-C, SP-D, elastin, VEGF-A, VEGFR2, ACE,
PTHrP, and PPAR in the fetal lungs were not affected by
leptin administration (Figure 4 and Table 4). Leptin
mRNA was not detected in the lungs of the sheep fetuses
treated with saline or leptin. In the saline-infused fetuses,
plasma leptin concentration on day 5 was positively cor-
related with SP-D mRNA (r  0.93, n  5, P  .05) and
inversely correlatedwithPTHrPmRNAlevels (r0.98,
n  5, P  .005).
Discussion
This study has demonstrated for the first time, in a species
like the humanwhere alveolar development occurs before
birth, that leptin administration matures aspects of lung
structure and increases pulmonary expression of the SP-B
gene involved in surfactant production. Specifically, 0.5
LEP treatment in fetal sheep, that elevated circulating lep-
tin concentration by 5- to 7-fold for 5 days, caused a re-
duction in alveolar diffusion distance and increased the
pulmonary volume at closing pressure, the density of sec-
ondary septal crests, elastin content in alveolar walls, and
the transcript levels of Ob-R and SP-B. Importantly, these
effects of leptin on lung function andmaturation occurred
without any change in plasma cortisol concentration,
which is well known to promote pulmonary maturation
before birth (3). Overall, the findings of the present study
support a key role for leptin in developmental and gluco-
corticoid-induced lung maturation in the fetus near term.
Leptin exposure in utero hadmoderate, but potentially
functional, consequences for thedeflation limbof thepres-
sure-volume curve measured in the ovine fetal lungs. No
changewas observed in V40 or static lung compliance, but
Figure 3. Mean  SEM relative mRNA abundance of (A) all forms of
the leptin receptor Ob-R and (B) the long-form leptin receptor Ob-Rb,
and relative protein expression of (C) the long-form leptin receptor and
(D) phosphorylated STAT3 relative to total STAT3, in the lungs of sheep
fetuses infused iv with either saline or leptin (0.5 or 1.0 LEP) for 5 days.
†, significantly different from saline group, unpaired Student’s t test,
P  .05.
Table 4. Mean  SEM Relative mRNA Abundance in
the Lungs of Sheep Fetuses Infused iv With Either Saline
or Leptin (0.5 or 1.0 LEP) for 5 Days
Saline (n  6) 0.5 LEP (n  10) 1.0 LEP (n  7)
Elastin 1.00  0.24 0.85  0.16 1.13  0.50
VEGF-A 1.00  0.11 0.81  0.14 0.64  0.12
VEGFR2 1.00  0.23 0.56  0.12 0.50  0.12
ACE 1.00  0.19 0.76  0.16 1.02  0.30
PPAR 1.00  0.17 0.83  0.08 1.11  0.28
PTHrP 1.00  0.16 1.28  0.27 0.91  0.15
Data are expressed as a fold change relative to the saline group.
Figure 4. Mean  SEM relative mRNA abundance of SP-A, B, C, and
D in the lungs of sheep fetuses infused iv with either saline or leptin
(0.5 or 1.0 LEP) for 5 days. For each gene, values with different letters
are significantly different from each other, one-way ANOVA, P  .05.
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the elevated plasma leptin concentration in the 0.5 LEP
group was associated with an increase in the lung volume
at 0 cmH2O closing pressure. This finding suggests that
the fetal lungs remained in a more expanded state at the
end of deflation, which may be a function of the elastic
properties of the lung tissue and/or the surface tension
forces and surfactant production by type II pneumocytes
(31). Indeed, in the 0.5 LEP group, the increase in lung
volume at closing pressure was associated with a signifi-
cant increase in pulmonary elastin content in the alveolar
walls, although no change in elastin mRNA abundance
was observed in response to leptin treatment. In addition,
thinning of the alveolar walls was induced by 0.5 LEP
treatment. Therefore, leptinmay contribute to the control
of structural remodeling of AT, and the development of
the elastic properties, that occurs in the fetal lung during
late gestation.
Previously, Ob-Rb protein has been localized to type II
pneumocytes in fetal ovine lungs, especially close to term,
which suggested that leptin may play a role in the activa-
tionof surfactantproduction (29). In thepresent study, the
mRNA abundance of SP-B was up-regulated by 0.5 LEP
treatment, although transcript levels of the other SPs were
unaffected by leptin treatment. Surfactant phospholipid
content was not determined in the present study andmea-
surements of saturated phosphatidylcholine and SP pro-
tein expression would be necessary to confirm the synthe-
sis and secretion of surfactant in response to leptin
administration in utero. However, the present findings
support, in part, those obtained previously froma series of
studies on fetal tissue in vitro. In lung explants obtained
from fetal rats, physiological concentrations of leptin in-
creased mRNA abundance of SP-A, SP-B, and SP-C, and
protein levels of SP-A and SP-B, and the synthesis of sur-
factant phospholipids (17, 19). In addition, antenatal
treatment of pregnant rats with leptin increased type II
pneumocyte number and SP expression in the fetal lungs
(19, 32). In the lungs ofXenopus laevis tadpoles cultured
in vitro, leptin exposure reduced the thickness of the al-
veolar walls and increased lamellar body size in associa-
tion with dose-dependent increases in both secreted SP-B
andC (33). In contrast, a study that administered leptin to
fetal sheep by an ultrasound-guided single im injection did
not show any changes in pulmonary function or SP syn-
thesis (34); however, in that experiment, recombinant hu-
man leptin was used, and it was difficult to assess the
effectiveness of treatment as plasma leptin concentration
in the fetus was not determined. In addition, fetal delivery
and tissue collection took place 3 days after the single
injection of leptin, at a time when leptin may have been
cleared from the circulation. In sheep, recombinant hu-
man leptin injected schadanestimated circulatinghalf-life
of 4 hours (35). In the present study, the iv infusion of
recombinant ovine leptin elevated leptin levels in the fetal
circulation from the first to the fifth day of treatment.
In rodent species, leptin has been proposed as an im-
portant signaling molecule in the paracrine interactions
between type II pneumocytes and lipofibroblasts that pro-
vide the lipid substrates for surfactant synthesis. Stretch of
the type II pneumocyte induces the release of PTHrP,
which acts on neighboring lipofibroblasts to stimulate up-
take, storage and trafficking of triglycerides mediated by
the actions of PPAR and leptin (21, 22). Studies using
fetal rat tissue in vitro have shown that dexamethasone
and PTHrP increase leptin mRNA abundance in pulmo-
nary lipofibroblasts and that PTHrP-induced phospho-
lipid synthesis is inhibited by an antileptin antibody in a
coculture of type II pneumocytes and lipofibroblasts (19).
In the sheep fetus, however, the absence of leptin mRNA
in the lungs at 130 days of gestation (29), and the lack of
effect of leptin treatment on PTHrP and PPAR genes in
the present study, suggests that thematurational effects of
leptin via Ob-Rb are likely to be endocrine, rather than by
local synthesis and paracrine actions of the hormone as
reported in the rodent species.
In the current study, the lower dose of recombinant
ovine leptin (0.5 LEP) was more effective than the higher
1.0 LEP dose in promoting aspects of lung maturation in
utero.Although significant responseswere observed in the
fetuses treated with 0.5 LEP, the higher dose of leptin had
no effect on the lung volume at closing pressure, alveolar
wall thickness, pulmonary elastin content or the mRNA
level of SP-B. The reasons for differences between the two
treatment groups are unclear, although in several cases,
larger interanimal variation may have contributed to the
lack of statistical significance in the values from the 1.0
LEP group. The circulating concentration of leptin
achieved in the 1.0 LEP group was significantly greater
than that seen in the 0.5 LEP group, and levels in both
groups of fetuses were higher than those normally seen in
fetal sheepnear term (10). Exposure to supraphysiological
leptin concentrations in utero may have influenced pul-
monary Ob-R expression and postreceptor signaling to
different extents in the two treatment groups. No signif-
icant differences in Ob-Rb or phosphorylated STAT3/
STAT3 protein levels were observed between the fetuses
infusedwith leptin or saline, although an increase inOb-R
mRNA abundance was induced by 0.5 LEP treatment;
these findings suggest changes in the control ofOb-R gene
transcription, protein translation and/or receptor protein
degradation which require further investigation. Of the
six known splice variants of the Ob-R gene, only the long
form of the leptin receptor, Ob-Rb, contains intracellular
motifs that can activate the Janus kinase/STAT intracel-
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lular signal transduction pathway (36). Phosphorylation
of STAT3results in the formationof anactivedimerwhich
translocates to the cell nucleus and binds to the promoter
region of target genes to control gene expression (36).
STAT3 is expressed in various cell types in the developing
lung, and studies in vitro have demonstrated that STAT3
can activate the promoter on the SP-B gene (37). In addi-
tion, differences in responses between the two leptin
groups may relate to changes in the pulmonary metabo-
lism of cortisol and expression of the glucocorticoid re-
ceptor which also remain to be determined. Furthermore,
the extent to which the actions of leptin on pulmonary
development before birth aremediated by immune and/or
central nervous pathways is unknown.
Intravenous infusion of recombinant ovine leptin in the
sheep fetus for 5 days was capable of mimicking some of
the effects of endogenous and exogenous glucocorticoids
on lung development in utero. However, leptin treatment
didnot influencepulmonarymRNAabundanceofACEor
SP-A, -C or -D, or the relative volumes of alveolar air-
space and tissue, which are known to be affected by glu-
cocorticoids before birth (3, 38, 39). The lack of effect of
leptin on the relative proportions of placentome types also
indicates that the effects of cortisol on placental morphol-
ogy (25) occur independent of the actions of leptin. A
greater understanding of the mechanisms by which glu-
cocorticoids exert their maturational effects on the fetal
lungs is crucial for the development of specific therapeutic
agents for the treatment of the respiratory consequences of
prematurity. This is of particular importance because
there is growing evidence that antenatal synthetic gluco-
corticoids have wide-ranging effects in the offspring with
potential long-termconsequences for postnatal health and
disease (40).
The findings of the present study also have implications
for lung development in macrosomic offspring. Umbilical
cord leptin concentration correlates with adiposity in hu-
man neonates (41, 42) and babies born to obese mothers,
and to those with gestational or type 1 diabetes, have
higher umbilical leptin concentrations at delivery com-
pared with those born to lean, nondiabetic mothers (43–
45). These infants are at increased risk of RDS in the neo-
natal period (46), an observation that appears to be
inconsistent with the findings of the present study. Im-
paired lung development in the offspring of obese and/or
diabetic mothers may be due primarily to the effects of
high circulating concentrations of glucose and insulin in
utero (47), which offset the potential maturational effects
of leptin. It is also possible, however, that longer term
exposure to leptin before birth may influence pulmonary
Ob-Rb expression and leptin signaling with adverse con-
sequences for lungmaturation and respiratory function at
birth. In adult life, chronic exposure to leptin associated
with obesity leads to resistance to the appetite-regulatory
actions of leptin at the hypothalamus (48, 49) and it may
be speculated that leptin insensitivity could arise in fetuses
overexposed to leptin. The present study has demon-
strated beneficial effects of leptin treatment on aspects of
lung development in the ovine fetus, at least over a 5-day
period and with a 5- to 7-fold increase in plasma leptin
concentration. The consequences of longer term leptin ex-
posure in utero need further investigation.
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